Position in FLNA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$19,607
-$39,532 QoQ
Shares Held
11,603
-61.2% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in FLNA Over Time
Shares Held
Position Value (USD)
Derivatives in FLNA
reported options exposure · as of Dec 31, 2022CallValue
$0
CallShares
0
PutValue
$570,122
PutShares
19,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. FLNA ranks #428 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in FLNA
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,607 | 11,603 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $59,139 | 29,869 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $549,968 | 188,993 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $344,052 | 190,085 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $818,722 | 545,815 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,196,512 | 930,726 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,615,531 | 88,873 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $778,209 | 63,013 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,719,090 | 84,726 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,887,148 | 83,836 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $460,361 | 27,666 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,564,326 | 63,798 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,403,879 | 58,204 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,230,281 | 41,648 | Shares | Defined | 2023-02-08 | |
| 2022-12-31 | $570,122 | 19,300 | Put | Defined | 2023-02-08 | |
| 2022-09-30 | $2,509,200 | 60,000 | Call | Defined | 2022-11-10 | |
| 2022-09-30 | $1,281,657 | 30,647 | Shares | Defined | 2022-11-10 | |
| 2022-09-30 | $807,126 | 19,300 | Put | Defined | 2022-11-10 | |
| 2022-06-30 | $542,716 | 19,300 | Put | Defined | 2022-08-10 | |
| 2022-06-30 | $139,531 | 4,962 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $233,424 | 6,285 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $701,946 | 18,900 | Put | Defined | 2022-05-16 | |
| 2021-12-31 | $338,063 | 7,736 | Shares | Defined | 2022-02-14 | |
| 2021-12-31 | $1,109,980 | 25,400 | Put | Defined | 2022-02-14 | |
| 2021-09-30 | $429,034 | 6,911 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $620,800 | 10,000 | Call | Defined | 2021-11-15 | |
| 2021-09-30 | $2,694,272 | 43,400 | Put | Defined | 2021-11-15 | |
| 2021-06-30 | $348,338 | 4,077 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $208,522 | 4,639 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $49,922 | 7,320 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $5,075 | 441 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $30,014 | 9,745 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $1,234,191 | 300,290 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||